1. Product Overview
1.1. Indication
1.2. Mechanism of Action
1.3. Dosage and Administration
1.4.1 Dosage Forms and Strengths
1.4. Route of Synthesis
1.5. Pharmacology
1.4.2 Pharmacodynamics
1.4.3 Pharmacokinetics
1.6. Adverse Reactions
1.7. Product Snapshot
1.8. Development Milestones of Rhopressa (netarsudil ophthalmic solution)
1.9. Marketed Details
1.4.4 United States
1.4.5 Europe
1.4.6 Japan
1.10. Patent Details

2. SWOT Analysis
2.1. Analyst Views

3. Regulatory Milestones
3.1. Approvals
3.2. Research and Development
3.3. Clinical Trials Information
3.4. Safety and Efficacy
3.5. Product Developmental Activities

4. Market Assessment
4.1. 7MM Market Analysis
4.2. United States
4.3. Europe
4.4. Japan
4.5. Key Findings

5. Market Competitors

6. Emerging Therapies

7. Appendix
7.1. Report Purchase Options

List of Tables
Table 1 Rhopressa (netarsudil ophthalmic solution), Description
Table 2 Rhopressa (netarsudil ophthalmic solution), Trial Diversification
Table 3 Rhopressa (netarsudil ophthalmic solution), Marketed Details United States
Table 4 Rhopressa (netarsudil ophthalmic solution), Marketed Details Europe
Table 5 Rhopressa (netarsudil ophthalmic solution), Marketed Details Japan
Table 6 Patent Details: Rhopressa (netarsudil ophthalmic solution)
Table 7 Rhopressa (netarsudil ophthalmic solution), Clinical Trial Description, 2020
Table 8 Safety and Efficacy Results for Rhopressa (netarsudil ophthalmic solution)
Table 9 Rhopressa (netarsudil ophthalmic solution), 7MM Market Size from 2017 to 2030 (in Million USD)
Table 10 Rhopressa (netarsudil ophthalmic solution), US Market Size from 2017 to 2030 (in Million USD)
Table 11 Rhopressa (netarsudil ophthalmic solution), EU Market Size from 2017 to 2030 (in Million USD)
Table 12 Rhopressa (netarsudil ophthalmic solution), EU5 Market Size from 2017 to 2030 (in Millions USD)
Table 13 Rhopressa (netarsudil ophthalmic solution), Japan Market Size from 2017 to 2030 (in Million USD)
Table 14 Market Competitors
Table 15 Emerging Therapies

List of Figures
Figure 1 The Development Timeline of Rhopressa (netarsudil ophthalmic solution)
Figure 2 Patent Details, Rhopressa (netarsudil ophthalmic solution)
Figure 3 Rhopressa (netarsudil ophthalmic solution), 7MM Market Size from 2017 to 2030 (in Million USD)
Figure 4 Rhopressa (netarsudil ophthalmic solution), US Market Size from 2017 to 2030 (in Millions USD)
Figure 5 Rhopressa (netarsudil ophthalmic solution), EU Market Size from 2017 to 2030 (in Millions USD)
Figure 6 Rhopressa (netarsudil ophthalmic solution), EU5 Market Size from 2017 to 2030 (in Millions USD)
Figure 7 Rhopressa (netarsudil ophthalmic solution), Japan Market Size from 2017 to 2030 (in Millions USD)